Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Standard

Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics. / Dalton, Susanne Oksbjerg; Johansen, Christoffer.

I: The Lancet, Bind 403, Nr. 10434, 2024, s. 1312-1313.

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Harvard

Dalton, SO & Johansen, C 2024, 'Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics', The Lancet, bind 403, nr. 10434, s. 1312-1313. https://doi.org/10.1016/S0140-6736(24)00303-9

APA

Dalton, S. O., & Johansen, C. (2024). Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics. The Lancet, 403(10434), 1312-1313. https://doi.org/10.1016/S0140-6736(24)00303-9

Vancouver

Dalton SO, Johansen C. Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics. The Lancet. 2024;403(10434):1312-1313. https://doi.org/10.1016/S0140-6736(24)00303-9

Author

Dalton, Susanne Oksbjerg ; Johansen, Christoffer. / Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics. I: The Lancet. 2024 ; Bind 403, Nr. 10434. s. 1312-1313.

Bibtex

@article{929adf4e5ac1479ca9c2d246ddeec1dc,
title = "Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics",
abstract = "Cancer clinics are focused on treating cancer as a somatic condition affecting the patient. However, with improvements in early diagnostics and treatment options, not only are patients living longer, but they want to be seen as people. Millions of people worldwide live with a cancer diagnosis, which, in addition to cancer treatment, affects physical health and psychosocial aspects of life (ie, anxiety or depression).1 For many cancer survivors, decades of life are characterised by periods of treatment and no treatment due to recurrence, metastases, and the increased risk for a new primary cancer.2 These issues call for rethinking the content of cancer clinics to accommodate for the increasing number of patients and address the somatic and psychosocial effects of treatment.",
author = "Dalton, {Susanne Oksbjerg} and Christoffer Johansen",
year = "2024",
doi = "10.1016/S0140-6736(24)00303-9",
language = "English",
volume = "403",
pages = "1312--1313",
journal = "The Lancet",
issn = "0140-6736",
publisher = "TheLancet Publishing Group",
number = "10434",

}

RIS

TY - JOUR

T1 - Integrating management of treatment toxicity on patient quality of life in real-world cancer clinics

AU - Dalton, Susanne Oksbjerg

AU - Johansen, Christoffer

PY - 2024

Y1 - 2024

N2 - Cancer clinics are focused on treating cancer as a somatic condition affecting the patient. However, with improvements in early diagnostics and treatment options, not only are patients living longer, but they want to be seen as people. Millions of people worldwide live with a cancer diagnosis, which, in addition to cancer treatment, affects physical health and psychosocial aspects of life (ie, anxiety or depression).1 For many cancer survivors, decades of life are characterised by periods of treatment and no treatment due to recurrence, metastases, and the increased risk for a new primary cancer.2 These issues call for rethinking the content of cancer clinics to accommodate for the increasing number of patients and address the somatic and psychosocial effects of treatment.

AB - Cancer clinics are focused on treating cancer as a somatic condition affecting the patient. However, with improvements in early diagnostics and treatment options, not only are patients living longer, but they want to be seen as people. Millions of people worldwide live with a cancer diagnosis, which, in addition to cancer treatment, affects physical health and psychosocial aspects of life (ie, anxiety or depression).1 For many cancer survivors, decades of life are characterised by periods of treatment and no treatment due to recurrence, metastases, and the increased risk for a new primary cancer.2 These issues call for rethinking the content of cancer clinics to accommodate for the increasing number of patients and address the somatic and psychosocial effects of treatment.

U2 - 10.1016/S0140-6736(24)00303-9

DO - 10.1016/S0140-6736(24)00303-9

M3 - Comment/debate

C2 - 38490232

VL - 403

SP - 1312

EP - 1313

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 10434

ER -

ID: 387071260